Polyethylene glycol 3350 17000 MG Powder for Oral Solution — RxCUI 876193
RxNorm drug concept · Semantic clinical drug
RxCUI 876193
Semantic clinical drug · SCD
● Current RxNorm concept 102 FDA products
270 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI876193
Official namePolyethylene glycol 3350 17000 MG Powder for Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known aspolyethylene glycol 3350 17 GM Powder for Oral Solution
FDA products mapped102
Package NDCs mapped270
Reported Medicaid activity (SDUD)3,343,849 prescriptions · 50 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Polyethylene Glycol 3350: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- You can generally expect a bowel movement within 1 to 3 days after taking it. It's not meant to work in an hour like some other laxatives — it works gradually. If you haven't gone...
- How long does it take for Polyethylene Glycol 3350 to work?
- You can stir it into any 4 to 8 ounces of beverage — water, juice, coffee, tea, whatever you like, cold or hot. The key is to stir it well until it's completely dissolved. Don't dr...
- Can I mix it into any drink, or does it have to be water?
🕸️ Concept Web — How Polyethylene glycol 3350 17000 MG Powder for Ora... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Polyethylene glycol 3350 17000 MG Powder for Oral Solution
RxCUI 876193 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Polyethylene glycol 3350
221147IN
-
Polyethylene glycol 3350
-
Brand names 8
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
ClearLax
880403BN -
Comfortlax
2695446BN -
Dulcolax Osmotic
2724416BN -
Gavilax
876188BN -
GentleLax
1049420BN -
HealthyLax
1088528BN -
Miralax
261575BN -
PureLax
1010729BN
-
ClearLax
-
Dose forms 30
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Polyethylene glycol 3350 Powder for Oral Solution
1870358SCDF -
Polyethylene glycol 3350 Oral Powder Product
1870357SCDG -
Polyethylene glycol 3350 Oral Product
1162922SCDG -
Polyethylene glycol 3350 Powder for Oral Solution [ClearLax]
1870361SBDF -
Polyethylene glycol 3350 Powder for Oral Solution [Comfortlax]
2695450SBDF -
Polyethylene glycol 3350 Powder for Oral Solution [Dulcolax Osmotic]
2724420SBDF -
Polyethylene glycol 3350 Powder for Oral Solution [Gavilax]
1870369SBDF -
Polyethylene glycol 3350 Powder for Oral Solution [GentleLax]
1870373SBDF - +22 more in this family
-
Polyethylene glycol 3350 Powder for Oral Solution
-
Clinical & branded drugs 17
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Polyethylene glycol 3350 17000 MG
1870356SCDC -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [ClearLax]
880407SBD -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [Comfortlax]
2695451SBD -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [Dulcolax Osmotic]
2724421SBD -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax]
876214SBD -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [GentleLax]
1049423SBD -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [HealthyLax]
1088531SBD -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [Miralax]
876195SBD - +9 more in this family
-
Polyethylene glycol 3350 17000 MG
Showing up to 8 concepts per family — 25 of 56 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Polyethylene glycol 3350 17000 MG
SCDC · 1870356 -
Polyethylene glycol 3350 Powder for Oral Solution
SCDF · 1870358 -
Polyethylene glycol 3350 Oral Powder Product
SCDG · 1870357 -
Polyethylene glycol 3350 Oral Product
SCDG · 1162922
Brand-Name Concepts
-
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [ClearLax]
SBD · 880407 -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [Comfortlax]
SBD · 2695451 -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [Dulcolax Osmotic]
SBD · 2724421 -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [Gavilax]
SBD · 876214 -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [GentleLax]
SBD · 1049423 -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [Miralax]
SBD · 876195 -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [PureLax]
SBD · 1010732 -
Polyethylene glycol 3350 17000 MG Powder for Oral Solution [HealthyLax]
SBD · 1088531 -
Polyethylene glycol 3350 17000 MG [ClearLax]
SBDC · 1870360 -
Polyethylene glycol 3350 17000 MG [Comfortlax]
SBDC · 2695447
📦 FDA Products & Package NDCs
102 products · 270 package NDCs
270 package NDCs map to RxCUI 876193 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00113-0306-01 | 119 g in 1 BOTTLE (0113-0306-01) | Good Sense Clear Lax | L. Perrigo Company | 2009-10-08 |
| 00113-0306-02 | 238 g in 1 BOTTLE (0113-0306-02) | Good Sense Clear Lax | L. Perrigo Company | 2009-10-08 |
| 00113-0306-03 | 510 g in 1 BOTTLE (0113-0306-03) | Good Sense Clear Lax | L. Perrigo Company | 2009-10-07 |
| 00113-0306-09 | 765 g in 1 BOTTLE (0113-0306-09) | Good Sense Clear Lax | L. Perrigo Company | 2019-05-30 |
| 00113-1023-02 | 238 g in 1 BOTTLE (0113-1023-02) | good sense clearlax | L. Perrigo Company | 2023-05-15 |
| 00113-1023-03 | 510 g in 1 BOTTLE (0113-1023-03) | good sense clearlax | L. Perrigo Company | 2022-12-27 |
| 00113-6900-02 | 1 BOTTLE in 1 CARTON (0113-6900-02) / 238 g in 1 BOTTLE | injoy constipation relief | L. Perrigo Company | 2022-08-09 |
| 00363-0306-02 | 238 g in 1 BOTTLE (0363-0306-02) | smooth lax | Walgreen Company | 2009-10-09 |
| 00363-0306-03 | 510 g in 1 BOTTLE (0363-0306-03) | smooth lax | Walgreen Company | 2009-10-09 |
| 00363-0306-09 | 765 g in 1 BOTTLE (0363-0306-09) | smooth lax | Walgreen Company | 2015-04-10 |
| 00363-0306-19 | 595 g in 1 BOTTLE (0363-0306-19) | smooth lax | Walgreen Company | 2024-12-14 |
| 00363-0306-52 | 10 POUCH in 1 CARTON (0363-0306-52) / 17 g in 1 POUCH (0363... | smooth lax | Walgreen Company | 2010-04-27 |
| 00363-0306-60 | 20 POUCH in 1 CARTON (0363-0306-60) / 17 g in 1 POUCH (0363... | smooth lax | Walgreen Company | 2019-05-28 |
| 00363-1323-02 | 238 g in 1 BOTTLE (0363-1323-02) | smoothlax | Walgreen Company | 2024-03-12 |
| 00363-1323-03 | 510 g in 1 BOTTLE (0363-1323-03) | smoothlax | Walgreen Company | 2023-02-10 |
| 00363-5260-07 | 119 g in 1 BOTTLE, PLASTIC (0363-5260-07) | Walgreens | WALGREEN COMPANY | 2023-03-01 |
| 00363-5260-14 | 238 g in 1 BOTTLE, PLASTIC (0363-5260-14) | Walgreens | WALGREEN COMPANY | 2023-03-01 |
| 00536-1052-24 | 238 g in 1 BOTTLE (0536-1052-24) | rugby PEG 3350 | Rugby Laboratories | 2015-01-05 |
| 00536-1052-27 | 510 g in 1 BOTTLE (0536-1052-27) | rugby PEG 3350 | Rugby Laboratories | 2015-01-05 |
| 00536-1052-60 | 119 g in 1 BOTTLE (0536-1052-60) | rugby PEG 3350 | Rugby Laboratories | 2024-07-25 |
| 00536-1052-84 | 850 g in 1 BOTTLE (0536-1052-84) | rugby PEG 3350 | Rugby Laboratories | 2015-01-05 |
| 00904-6931-26 | 14 PACKET in 1 CARTON (0904-6931-26) / 17 g in 1 PACKET | Polyethylene glycol 3350 | Major Pharmaceuticals | 2019-06-30 |
| 00904-6931-76 | 30 PACKET in 1 CARTON (0904-6931-76) / 17 g in 1 PACKET | Polyethylene glycol 3350 | Major Pharmaceuticals | 2019-06-30 |
| 00904-6931-81 | 100 PACKET in 1 CARTON (0904-6931-81) / 17 g in 1 PACKET | Polyethylene glycol 3350 | Major Pharmaceuticals | 2019-06-30 |
| 00904-6931-86 | 17 g in 1 PACKET (0904-6931-86) | Polyethylene glycol 3350 | Major Pharmaceuticals | 2019-06-30 |
| 11523-0122-01 | 238 g in 1 BOTTLE (11523-0122-1) | MiraLAX Orange Flavor | Bayer HealthCare LLC. | 2023-09-15 |
| 11523-0122-02 | 119 g in 1 BOTTLE (11523-0122-2) | MiraLAX Orange Flavor | Bayer HealthCare LLC. | 2023-09-15 |
| 11523-4357-02 | 2 CARTON in 1 CARTON (11523-4357-2) / 20 PACKET in 1 CARTON... | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-4357-03 | 2 BOTTLE, PLASTIC in 1 PACKAGE, COMBINATION (11523-4357-3)... | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-4357-05 | 24 PACKET in 1 CARTON (11523-4357-5) / 17 g in 1 PACKET | MiraLAX | Bayer HealthCare LLC. | 2018-05-01 |
| 11523-7234-01 | 17 g in 1 PACKET (11523-7234-1) | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7234-02 | 119 g in 1 BOTTLE, PLASTIC (11523-7234-2) | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7234-03 | 238 g in 1 BOTTLE, PLASTIC (11523-7234-3) | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7234-04 | 510 g in 1 BOTTLE, PLASTIC (11523-7234-4) | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7234-06 | 17 g in 1 PACKET (11523-7234-6) | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7268-03 | 10 PACKET in 1 CARTON (11523-7268-3) / 17 g in 1 PACKET | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7268-04 | 765 g in 1 BOTTLE, PLASTIC (11523-7268-4) | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7268-05 | 850 g in 1 BOTTLE, PLASTIC (11523-7268-5) | MiraLAX | Bayer HealthCare LLC. | 2025-05-30 |
| 11523-7268-08 | 24 PACKET in 1 CARTON (11523-7268-8) / 17 g in 1 PACKET | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7268-09 | 20 POUCH in 1 CARTON (11523-7268-9) / 17 g in 1 POUCH | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7341-01 | 612 g in 1 BOTTLE, PLASTIC (11523-7341-1) | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11523-7341-02 | 3 PACKET in 1 CARTON (11523-7341-2) / 17 g in 1 PACKET | MiraLAX | Bayer HealthCare LLC. | 2007-02-01 |
| 11534-0180-19 | 119 g in 1 BOTTLE (11534-180-19) | POLYETHYLENE GLYCOL 3350 NF | SUNRISE PHARMACEUTICAL, INC | 2017-06-13 |
| 11534-0180-28 | 238 g in 1 BOTTLE (11534-180-28) | POLYETHYLENE GLYCOL 3350 NF | SUNRISE PHARMACEUTICAL, INC | 2017-06-13 |
| 11534-0180-50 | 510 g in 1 BOTTLE (11534-180-50) | POLYETHYLENE GLYCOL 3350 NF | SUNRISE PHARMACEUTICAL, INC | 2017-06-13 |
| 11673-0306-01 | 119 g in 1 BOTTLE (11673-306-01) | up and up powderlax | Target Corporation | 2019-04-12 |
| 11673-0306-02 | 238 g in 1 BOTTLE (11673-306-02) | up and up powderlax | Target Corporation | 2009-10-07 |
| 11673-0306-03 | 510 g in 1 BOTTLE (11673-306-03) | up and up powderlax | Target Corporation | 2009-10-07 |
| 11673-0306-09 | 765 g in 1 BOTTLE (11673-306-09) | up and up powderlax | Target Corporation | 2016-10-21 |
| 11822-0306-01 | 765 g in 1 BOTTLE (11822-0306-1) | Laxative | Rite Aid Corporation | 2023-02-23 |
Observed labelers:
Bayer HealthCare LLC. (17) ·
Atlantic Biologicals Corp. (11) ·
WALGREEN COMPANY (10) ·
Camber Consumer Care Inc (9) ·
CVS Pharmacy (9) ·
Amazon.com Services LLC (8)
· +65 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.